DENTSPLY SIRONA (XRAY) Stock Rating Upgraded by William Blair

Share on StockTwits

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by analysts at William Blair from a “market perform” rating to an “outperform” rating in a report released on Monday, March 18th, Marketbeat reports. The firm presently has a $56.71 price objective on the medical instruments supplier’s stock. William Blair’s price target points to a potential upside of 15.64% from the stock’s current price. William Blair also issued estimates for DENTSPLY SIRONA’s FY2021 earnings at $3.00 EPS.

Several other brokerages also recently commented on XRAY. Robert W. Baird boosted their target price on shares of DENTSPLY SIRONA from $42.00 to $50.00 and gave the company a “neutral” rating in a research note on Monday, March 4th. UBS Group boosted their target price on shares of DENTSPLY SIRONA from $42.00 to $53.00 and gave the company a “neutral” rating in a research note on Tuesday, March 12th. HC Wainwright reiterated a “neutral” rating and set a $49.00 price target (up previously from $40.00) on shares of DENTSPLY SIRONA in a research report on Monday, March 4th. Barclays set a $49.00 price target on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Friday, March 1st. Finally, Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $55.00 price target on the stock in a research report on Saturday, March 9th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and seven have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $51.58.

XRAY traded down $0.20 during trading on Monday, reaching $49.04. 15,170 shares of the company’s stock were exchanged, compared to its average volume of 2,159,863. DENTSPLY SIRONA has a fifty-two week low of $33.93 and a fifty-two week high of $53.10. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.86 and a quick ratio of 1.27. The company has a market capitalization of $10.96 billion, a P/E ratio of 24.36, a P/E/G ratio of 2.21 and a beta of 1.08.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Friday, March 1st. The medical instruments supplier reported $0.58 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.04. DENTSPLY SIRONA had a negative net margin of 25.36% and a positive return on equity of 8.21%. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the previous year, the company earned $0.82 EPS. The firm’s revenue for the quarter was down 2.9% compared to the same quarter last year. On average, equities research analysts expect that DENTSPLY SIRONA will post 2.31 EPS for the current fiscal year.

Large investors have recently made changes to their positions in the business. Harel Insurance Investments & Financial Services Ltd. bought a new stake in DENTSPLY SIRONA during the 4th quarter worth about $26,000. Private Capital Group LLC raised its holdings in DENTSPLY SIRONA by 105.3% during the 4th quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 359 shares during the last quarter. Pinnacle Bank bought a new stake in DENTSPLY SIRONA during the 4th quarter worth about $26,000. Truehand Inc bought a new stake in DENTSPLY SIRONA during the 4th quarter worth about $27,000. Finally, Enlightenment Research LLC bought a new stake in DENTSPLY SIRONA during the 4th quarter worth about $30,000. 96.30% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Recommended Story: Day Trading – Risk Worth the Reward?

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

North American Palladium  Upgraded at ValuEngine
North American Palladium Upgraded at ValuEngine
ValuEngine Lowers Investors Real Estate Trust Reit  to Hold
ValuEngine Lowers Investors Real Estate Trust Reit to Hold
The GEO Group  Cut to Sell at ValuEngine
The GEO Group Cut to Sell at ValuEngine
B&G Foods  Downgraded by ValuEngine
B&G Foods Downgraded by ValuEngine
ValuEngine Upgrades Iamgold  to Hold
ValuEngine Upgrades Iamgold to Hold
US Ecology  Upgraded by ValuEngine to “Buy”
US Ecology Upgraded by ValuEngine to “Buy”


 
© 2006-2019 Zolmax.